Mediaplanet and Aperio partner to educate Americans about Personalized Health and Medicine
NEW YORK, Oct. 23, 2012 /PRNewswire/ — On September 28, 2012, Mediaplanet released its first edition of “Personalized Health and Medicine” in USA Today, a 16-page publication. In this issue, Mediaplanet introduces its readers to technologies, such as ePathology, that are vital in the delivery of personalized medicine and improved patient care.
The importance of ePathology for both healthcare organizations and patients
Traditional pathology practice involves a pathologist reviewing a glass slide under a microscope to identify disease. Mistakes made today are headline news – like the story of Argentine President Cristina Fernandez de Kirchner, who was told she had thyroid cancer. Her thyroid gland was surgically removed. It was revealed afterward that she never had cancerous cells. Or take the case of a Los Angeles resident whose pathology case was identified as breast cancer. She underwent a double mastectomy and reconstruction only to later learn she never had cancer. The public is well aware of these errors and wants to select providers that they can trust. In this age of digital processes, it is important for pathology to make this leap forward.
The potential of ePathology continues to evolve; with increasing sub-specialization of pathologists, many organizations want to enable the best-trained physician to review the results. Unlike glass slides that need to be packed and shipped from one location to another, eSlides can be shared with a speed and certainty that was inconceivable a generation ago. Furthermore, ePathology can improve transparency and thus advance quality assurance, and by facilitating the use of companion diagnostics, ePathology can also enable the selection of the most effective therapy. Most importantly, ePathology is bringing the healthcare team closer to the patient.
Many organizations are beginning to consider the importance of ePathology, taking digital images, eSlides, into clinical use, so that they can integrate this expertise to deliver better patient care.
For over a decade, Aperio has advanced the technology that enables glass slides to be digitized and securely shared with others. Aperio ePathology Solutions are transforming the practice of pathology in hospitals, reference labs, and pharmaceutical and research institutions around the world. Aperio products are FDA cleared for specific clinical applications, and are intended for research and educational use for other applications. They are not approved by the FDA for primary diagnosis. For clearance updates, specific product indications, and more information, please visit www.aperio.com.
Mediaplanet publishes focused reports on specific business, healthcare, technology or consumer topics.
To view the full publication and to find out more about ePathology: click here.
CONTACT: Megan Brunhofer, email@example.com, +1-646-755-7961